We will exhibit at BIO-Europe Fall 2026, where biotechnology and pharmaceutical leaders will meet to explore potential partnerships and discuss the decisions shaping clinical development. Visit us at booth 8-38 to meet our team.
At Clarenta, we connect scientific and regulatory strategy with operational delivery. Whether you are preparing an early development strategy, evaluating European trial options or planning the next stage of an established programme, we can help you assess feasibility, identify risks early and understand the considerations that may influence timelines and delivery.
Meet our team
- > Diana Gheorghi, Director, Business Development
- > Biljana Stuparevic, Director, Business Development
- > Martina Forte, Head of Marketing
Our team will be available to discuss clinical development strategy, early phase clinical trials, European feasibility and the scientific, regulatory and operational considerations that may influence what comes next.
If you are attending BIO-Europe Fall 2026, arrange a meeting with us through partneringONE or visit our team at booth 8-38.
